NCT00466986
- Conditions
- Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +21 more
- Locations
-
- Southeastern Gynecologic Oncology Atlanta, Georgia, United States
Clinical trial condition
Primary Peritoneal Cancer
Explore clinical trials studying Primary Peritoneal Cancer. Study availability and eligibility vary by location and protocol.
91 public trials
21 recruiting studies
Primary Peritoneal Cancer trial results
Completed
Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer
NCT00489359
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bahía Blanca, Argentina
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buenos Aires, Argentina
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ramos Mejía, Argentina
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salta, Argentina
NCT00562003
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- UAB Highlands, 1201 11th Ave S, 4th Floor, Gynecologic Oncology Birmingham, Alabama, United States
Completed
Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma
NCT00157560
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT00109096
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brussels, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Erlangen, Germany
Active, Not Recruiting
"Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT01883297
- Conditions
- Adnexal Diseases, Disease Attributes, Fallopian Tube Cancer, +18 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Active, Not Recruiting
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
NCT03872947
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +58 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- AOA-HOPE Tucson, Arizona, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- HOAG Memorial Hospital Presbyterian Newport, California, United States
Active, Not Recruiting
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
NCT03393884
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
- Mitchell Cancer Institute (University of South Alabama) Mobile, Alabama, United States
- Gynecologic Oncology Associates (Hoag Hospital) Newport Beach, California, United States
- Innovative Clinical Research Whittier, California, United States
NCT05053750
- Conditions
- Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Cancer
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery
NCT02884648
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States